- Campbell JR, Johnston JC, Ronald LA, Sadatsafavi M, Balshaw RF, Cook VJ, et al. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019;73(1):39-50.
- Castillo-Jimenez DA, Garcia-Perdomo HA. Re: Niranjan J. Sathianathen, Badrinath R. Konety, Fernando Alarid-Escudero, Nathan Lawrentschuk, Damien M. Bolton, Karen M. Kuntz. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.055: Standardized Reporting for Economic Analyses Should be Mandatory. European urology. 2019.
- Culyer AJ, Chalkidou K. Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2019;22(1):99-103.
- Wang SY, Chen T, Dang W, Mougalian SS, Evans SB, Gross CP. Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis. Journal of the National Comprehensive Cancer Network : JNCCN. 2019;17(1):39-46.
- Yang F, Devlin N, Luo N. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2019;22(1):45-9.
HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Monday 18 February 2019
January’s CEAs.....
We’ve completed our quick search for CEA’s published last month. In the right-hand column of this blog is a CEA Archive of all records. Below are those in our areas of interest.